HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Estee Lauder DayWear reformulation with antioxidant blend highlighted in ad campaign.

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

ESTEE LAUDER DAYWEAR REFORMULATION BACKED BY NEW ADS highlighting the results of a French study that examined the beneficial properties of antioxidants. The study tested an antioxidant blend that included vitamins C and E, ubiquine and other ingredients for which Estee Lauder has filed a patent and has incorporated into DayWear products. The reformulated DayWear Antioxidant Creme SPF 15 and the new DayWear Antioxidant SPF 15 Lotion are reaching U.S. and Canadian counters in May.

Table

View full table

Tags:
Latest Headlines

Over The Counter: Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta

Coty’s Social Media Investments Have CoverGirl, Rimmel On More Lips, Minds And Receipts

Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results

Kenvue Cutting Staff 4% After Year Apart From J&J

See All
UsernamePublicRestriction

Register

RS005365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By